论文部分内容阅读
本文分析了我院1996年和1997年抗肿瘤药在我院所占药品消耗金额比重。结果表明，1996年和1997年抗肿瘤药金额分别占药品总金额的8.80％和10.81％。其中抗肿瘤植物药分别占抗肿瘤药总金额的14.70％和19.44％。而抗肿瘤辅助药分别占抗肿瘤药总金额的66.43％和61.55％。这两年抗肿瘤药金额的近1／3用在少数新、特、进口药上，这是值得注意的问题。另外，基本药物目录中的抗肿瘤药品占有较高比例。
This article analyzes our hospital in 1996 and 1997 anti-tumor drugs in our hospital accounted for the proportion of the amount of drug consumption. The results show that in 1996 and 1997 the total amount of antineoplastic drugs accounted for 8.80% and 10.81% of the total amount. Anti-tumor drugs which accounted for 14.70% and 19.44% of the total amount of anti-tumor drugs. The antitumor adjuvant drugs accounted for 66.43% and 61.55% of the total amount of antitumor drugs. Nearly one-third of the amount of antineoplastic medicine in these two years is spent on a few new, special and imported medicines, which is a notable issue. In addition, the list of essential medicines antitumor drugs occupy a higher proportion.